Roche Czech Republic - Net Debt Growth

Created with Highcharts 6.0.4%2004200520062007200820092010201120122013201420152016-50k-40k-30k-20k-10k010k

Roche CR`s Net Debt Growth reached -69.2 % in 2016. This is 416 % less than in the previous year.

$1.99

Buy Net Debt Growth data for Roche Czech Republic.

$19.99

Buy all data for Roche Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

 
CompanyUnit
Amgen Czech Republic %
Bayer Czech Republic %
GlaxoSmithKline Czech Republic %
Merck Czech Republic %
Novartis Czech Republic %
Pfizer Czech Republic %
Roche Czech Republic %
Sanofi-Aventis Czech Republic %
Servier Czech Republic %
Walmark %
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
... ... ... ... ...           ... ... ... -17,482 83.3    
... ... ...               -71.1 -78.0 -272 13.5 595    
... ... ...               -18.8 76.2 33.3 -100 266,920    
... ...                 13.5 -7.53 18.5 -86.2 -113    
                    141 -75.5 -109 -2,141 -102    
... ...                 -703 -113 -72.3 1,069 -98.5    
... ... ...               -100 -40,192 88.9 90.0 21.9   ...
... ... ... ...             -4.00 14.4 -34.2 -46.3 -14.4    
... ... ... ... ... ... ... ... ... ... ... ... 41.6 -14.0 -44.7    
... ... ...               -41.2 340 -22.8 -12.0 166